Blog Posts
Misty Shields: A “Master Class” on RPA in SCLC by Shadia I Jalal
Photo taken from Misty Shields/X

Misty Shields: A “Master Class” on RPA in SCLC by Shadia I Jalal

Misty Shields, Indiana University School of Medicine, shared on X/Twitter:

“A “Master Class” on RPA in SCLC by Shadia I Jalal.

  • RPA inhibitor NERx 329 induces catastrophic stress in SCLC.
  •  Pre-clinically effective in SCLC.
  • More to come from NERx.”

Misty Shields: A “Master Class” on RPA in SCLC by Shadia I Jalal

Source: Misty Shields/X

cancer Misty Shields NERx OncoDaily Oncology RPA inhibitor Shadia I Jalal